Education
About Us
Working with TipRanks
Follow Us
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
BALAXI Stock Chart & Stats
₹27.83
-₹2.28(-2.93%)
At close: 4:00 PM EST
₹27.83
-₹2.28(-2.93%)
Day’s Range― - ―
52-Week Range₹27.50 - ₹84.00
Previous CloseN/A
Volume27.88K
Average Volume (3M)75.37K
Market Cap
₹307.28M
Enterprise ValueN/A
Total Cash (Recent Filing)₹407.03M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)7.7
Beta0.97
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,041,500
10 Day Avg. Volume158,740
30 Day Avg. Volume75,367
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.60
Price to Sales (P/S)1.28
P/FCF Ratio-6.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Balaxi Pharmaceuticals Limited News
BALAXI FAQ
What was Balaxi Pharmaceuticals Limited’s price range in the past 12 months?
Balaxi Pharmaceuticals Limited lowest stock price was ₹27.50 and its highest was ₹84.00 in the past 12 months.
What is Balaxi Pharmaceuticals Limited’s market cap?
Balaxi Pharmaceuticals Limited’s market cap is ₹307.28M.
When is Balaxi Pharmaceuticals Limited’s upcoming earnings report date?
Balaxi Pharmaceuticals Limited’s upcoming earnings report date is Feb 05, 2026 which is in 45 days.
How were Balaxi Pharmaceuticals Limited’s earnings last quarter?
Currently, no data Available
Is Balaxi Pharmaceuticals Limited overvalued?
According to Wall Street analysts Balaxi Pharmaceuticals Limited’s price is currently Overvalued.
Does Balaxi Pharmaceuticals Limited pay dividends?
Balaxi Pharmaceuticals Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Balaxi Pharmaceuticals Limited dividends here
What is Balaxi Pharmaceuticals Limited’s EPS estimate?
Balaxi Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Balaxi Pharmaceuticals Limited have?
Balaxi Pharmaceuticals Limited has 11,041,500 shares outstanding.
What happened to Balaxi Pharmaceuticals Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Balaxi Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:BALAXI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited (BALAXI) is a pharmaceutical company engaged in the research, development, manufacture, and marketing of a wide range of pharmaceutical products. The company focuses primarily on therapeutic areas such as cardiology, neurology, and infectious diseases, offering both prescription medications and over-the-counter products. With a commitment to innovation and quality, BALAXI aims to improve patient outcomes through its advanced drug formulations and comprehensive healthcare solutions.
Technical Analysis
Biofil Chemicals & Pharmaceuticals Ltd.
―
Gkb Ophthalmics Limited
―
Ind-Swift Ltd.
―
Lasa Supergenerics Ltd.
―
Vivimed Labs Limited
―